**Core Concept**
Multiple myeloma is a type of blood cancer characterized by the proliferation of malignant plasma cells in the bone marrow, leading to an excessive production of monoclonal immunoglobulins (M-protein) and bone destruction. This results in various clinical manifestations, including bone pain, anemia, renal failure, and increased susceptibility to infections.

**Why the Correct Answer is Right**
The correct answer will be one that does not accurately describe a characteristic of multiple myeloma. Multiple myeloma is indeed characterized by the excessive production of monoclonal immunoglobulins (M-protein), which can lead to hyperviscosity syndrome, amyloidosis, and other complications. Bone destruction in multiple myeloma is mediated by the production of osteoclast-activating factors by the malignant plasma cells, leading to lytic bone lesions.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option may be true about multiple myeloma.
* **Option B:** This option may be true about multiple myeloma.
* **Option C:** This option may be true about multiple myeloma.

**Clinical Pearl / High-Yield Fact**
It is essential to distinguish multiple myeloma from other causes of bone pain and anemia, such as osteoporosis, lymphoma, and chronic kidney disease. A serum protein electrophoresis (SPEP) and a 24-hour urine protein electrophoresis (UPEP) can help diagnose multiple myeloma by detecting the presence of M-protein.

**Correct Answer:** D.